Product Wiki · Recalls · Health Canada — Marketed Health Products

Archived — recall 24494

Health Canada — Marketed Health Products · Canada · 2004-03-17

As described by Health Canada — Marketed Health Products: Archived – Important Drug Safety Information: ZYPREXA (olanzapine) and Cerebrovascular Adverse Events in Placebo-Controlled Elderly Dementia Trials

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
Health Canada — Marketed Health Products
Recall identifier
24494
Date of alert
2004-03-17
Country / jurisdiction
Canada
Risk type
recall
Product category
Health products
Product type
Marketed health products
Notice status
Archived by the issuing authority — kept for reference
Reported risk: ZYPREXA* (olanzapine) and Cerebrovascular Adverse Events in Placebo-Controlled Elderly Dementia Trials
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/archived-important-drug-safety

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.